Irving D. Kaplan
#173,188
Most Influential Person Now
American radiation oncologist
Irving D. Kaplan's AcademicInfluence.com Rankings
Irving D. Kaplanphilosophy Degrees
Philosophy
#11380
World Rank
#15667
Historical Rank
#2164
USA Rank
Logic
#8200
World Rank
#10223
Historical Rank
#1321
USA Rank
Download Badge
Philosophy
Why Is Irving D. Kaplan Influential?
(Suggest an Edit or Addition)According to Wikipedia, Irving David Kaplan is an American radiation oncologist at Beth Israel Deaconess Medical Center in Boston Massachusetts and an Assistant Professor at Harvard Medical School. Kaplan attended Medical School at Stanford University School of Medicine in 1985, interned at Kaiser Foundation Hospital in Internal Medicine at Santa Barbara in 1986. He Completed his residency in Radiation Oncology at Standard in 1989.
Irving D. Kaplan's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Biochemical Outcome after radical prostatectomy, external beam Radiation Therapy, or interstitial Radiation therapy for clinically localized prostate cancer (1998) (2100)
- Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. (1999) (1669)
- Quality of life and satisfaction with outcome among prostate-cancer survivors. (2008) (1335)
- Stereotactic body radiotherapy for localized prostate cancer: pooled analysis from a multi-institutional consortium of prospective phase II trials. (2013) (401)
- Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer. (1999) (381)
- Patient-reported symptoms after primary therapy for early prostate cancer: results of a prospective cohort study. (1998) (321)
- Prediction of erectile function following treatment for prostate cancer. (2011) (284)
- Stereotactic radiosurgical treatment of brain metastases. (1992) (255)
- Time course and predictors of symptoms after primary prostate cancer therapy. (2003) (234)
- Stereotaxic radiosurgery for brain metastases: the importance of adjuvant whole brain irradiation. (1992) (205)
- Complications after treatment with external-beam irradiation in early-stage prostate cancer patients: a prospective multiinstitutional outcomes study. (1997) (194)
- Hypofractionated stereotactic body radiotherapy in low‐risk prostate adenocarcinoma (2012) (173)
- Long-term Outcomes of Stereotactic Body Radiotherapy for Low-Risk and Intermediate-Risk Prostate Cancer (2019) (171)
- Prostate specific antigen after external beam radiotherapy for prostatic cancer: followup. (1993) (170)
- Real time MRI-ultrasound image guided stereotactic prostate biopsy. (2002) (162)
- Biochemical outcome following external beam radiation therapy with or without androgen suppression therapy for clinically localized prostate cancer. (2000) (158)
- Early and late bone-marrow changes after irradiation: MR evaluation. (1990) (149)
- A critical examination of the results from the Harvard-MIT NCT program phase I clinical trial of neutron capture therapy for intracranial disease (2003) (126)
- Multidisciplinary care and pursuit of active surveillance in low-risk prostate cancer. (2012) (112)
- Equivalent biochemical failure-free survival after external beam radiation therapy or radical prostatectomy in patients with a pretreatment prostate specific antigen of > 4-20 ng/ml. (1997) (110)
- Pooled analysis of stereotactic ablative radiotherapy for primary renal cell carcinoma: A report from the International Radiosurgery Oncology Consortium for Kidney (IROCK) (2018) (104)
- The clinical utility of the percent of positive prostate biopsies in predicting biochemical outcome following external-beam radiation therapy for patients with clinically localized prostate cancer. (2001) (99)
- The importance of local control in the treatment of prostatic cancer. (1992) (80)
- Ipilmumab and cranial radiation in metastatic melanoma patients: a case series and review (2015) (79)
- 5 year biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer (1998) (78)
- Hypofractionated Stereotactic Body Radiotherapy in Low Risk Prostate Adenocarcinoma: Preliminary Results of a Multi-Institutional Phase I Feasibility Trial (2011) (73)
- Hyperthermia combined with radiation for the treatment of locally advanced prostate cancer (2011) (72)
- Patient-reported quality of life after stereotactic body radiotherapy (SBRT), intensity modulated radiotherapy (IMRT), and brachytherapy. (2015) (67)
- Serum prostate-specific antigen after post-prostatectomy radiotherapy. (1992) (60)
- The Emerging Role of Stereotactic Ablative Radiotherapy for Primary Renal Cell Carcinoma: A Systematic Review and Meta-Analysis. (2019) (57)
- Multicenter Trial of Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer: Survival and Toxicity Endpoints. (2018) (57)
- Prostate specific antigen after irradiation for prostatic carcinoma. (1990) (56)
- The clinical significance of a positive post-irradiation prostatic biopsy without metastases. (1992) (50)
- A model of prostatic carcinoma tumor kinetics based on prostate specific antigen levels after radiation therapy (1991) (48)
- Radiosurgery for palliation of base of skull recurrences from head and neck cancers (1992) (47)
- Prostate cancer in a transgender woman 41 years after initiation of feminization. (2006) (47)
- Organ deformation and dose coverage in robotic respiratory-tracking radiotherapy. (2008) (44)
- A pilot study of topical intrarectal application of amifostine for prevention of late radiation rectal injury. (2002) (43)
- Intrarectal application of amifostine for the prevention of radiation-induced rectal injury. (2002) (43)
- Patient Reported Outcomes in NRG Oncology RTOG 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate Cancer. (2018) (43)
- Prostate-specific antigen kinetics after external beam irradiation for carcinoma of the prostate. (1994) (43)
- Radiation-associated morbidity in patients undergoing small-field external beam irradiation for prostate cancer. (1998) (43)
- A comparison of the precision of seeds deposited as loose seeds versus suture embedded seeds: a randomized trial. (2004) (37)
- Ultrasound image fusion for external beam radiotherapy for prostate cancer. (1996) (37)
- Predictors of survival after a positive post-irradiation prostate biopsy. (1994) (36)
- Preliminary treatment planning and dosimetry for a clinical trial of neutron capture therapy using a fission converter epithermal neutron beam. (2004) (36)
- Feasibility and patient tolerance of a novel transrectal ultrasound hyperthermia system for treatment of prostate cancer. (2001) (35)
- Stereotactic Ablative Radiotherapy for ≥T1b Primary Renal Cell Carcinoma: A Report from the International Radiosurgery Oncology Consortium for Kidney (IROCK). (2019) (34)
- Prostate postbrachytherapy seed distribution: comparison of high-resolution, contrast-enhanced, T1- and T2-weighted endorectal magnetic resonance imaging versus computed tomography: initial experience. (2007) (34)
- Multi-institutional prospective evaluation of bowel quality of life after prostate external beam radiation therapy identifies patient and treatment factors associated with patient-reported outcomes: the PROSTQA experience. (2013) (34)
- A Phase 1 Dose-Escalation Study of Robotic Radiosurgery in Inoperable Primary Renal Cell Carcinoma (2013) (34)
- Hyperthermia combined with radiation in treatment of locally advanced prostate cancer is associated with a favourable toxicity profile (2005) (33)
- A 64-year-old man with low-risk prostate cancer: review of prostate cancer treatment. (2009) (33)
- Helium charged particle radiotherapy for meningioma: experience at UCLBL. University of California Lawrence Berkeley Laboratory. (1994) (32)
- Finasteride and flutamide therapy in patients with advanced prostate cancer: response to subsequent castration and long-term follow-up. (2003) (30)
- Real-time computed tomography dosimetry during ultrasound-guided brachytherapy for prostate cancer. (2006) (29)
- Effect of Stereotactic Body Radiotherapy on the Growth Kinetics and Enhancement Pattern of Primary Renal Tumors. (2016) (29)
- Clinical utility of percent-positive prostate biopsies in predicting biochemical outcome after radical prostatectomy or external-beam radiation therapy for patients with clinically localized prostate cancer. (2000) (27)
- Effect of random seed placement error in permanent transperineal prostate seed implant. (2006) (27)
- Secondary external-beam radiotherapy and hyperthermia for local recurrence after 125-iodine implantation in adenocarcinoma of the prostate. (1991) (27)
- Calculated prostate cancer volume greater than 4.0 cm3 identifies patients with localized prostate cancer who have a poor prognosis following radical prostatectomy or external-beam radiation therapy. (1998) (26)
- Multidisciplinary care and pursuit of active surveillance in low-risk prostate cancer. (2012) (26)
- The Harvard-MIT BNCT Program (2001) (24)
- Prostate cancer. Radiation therapy for localized disease. (1993) (24)
- Radiotherapy for prostatic cancer: patient selection and the impact of local control. (1994) (23)
- An automatic seed finder for brachytherapy CT postplans based on the Hough transform. (2004) (23)
- Equivalent 5-year bNED in select prostate cancer patients managed with surgery or radiation therapy despite exclusion of the seminal vesicles from the CTV. (1997) (22)
- Patient-Reported Outcomes in NRG Oncology/RTOG 0938, a Randomized Phase 2 Study Evaluating 2 Ultrahypofractionated Regimens (UHRs) for Prostate Cancer (2016) (21)
- Androgen deprivation-mediated cytoreduction before interstitial brachytherapy for prostate cancer does not abrogate the elevated risk of urinary morbidity associated with larger initial prostate volume. (2007) (21)
- Results of a Phase I Dose Escalation Study of Stereotactic Radiosurgery for Primary Renal Tumors (2010) (21)
- Lack of radiation dose response for patients with low-risk clinically localized prostate cancer: a retrospective analysis. (2002) (19)
- Reduction of spinal metastases after preemptive irradiation in prostatic cancer. (1990) (18)
- Intraoperative treatment planning for radioactive seed implant therapy for prostate cancer. (2000) (18)
- Development and validation of a pancreatic cancer risk model for the general population using electronic health records: An observational study. (2020) (17)
- Five-Year Outcomes From a Multicenter Trial of Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer (2016) (16)
- Stereotactic Radiotherapy as a Treatment Option for Renal Tumors in the Solitary Kidney: A Multicenter Analysis from the IROCK. (2019) (16)
- Using patient‐reported outcomes to assess and improve prostate cancer brachytherapy (2014) (16)
- Association of rectal toxicity with thermal dose parameters in treatment of locally advanced prostate cancer with radiation and hyperthermia. (2002) (16)
- Relief of Urinary Symptom Burden after Primary Prostate Cancer Treatment (2017) (15)
- Stereotactic Body Radiation Therapy for Localized Prostate Cancer (2016) (14)
- Investigating the clinical utility of the percent of positive prostate biopsies in predicting PSA outcome following local therapy for patients with clinically localized prostate cancer (2000) (14)
- Models of care and NCCN guideline adherence in very-low-risk prostate cancer. (2013) (14)
- Assessing a prostate cancer brachytherapy technique using early patient-reported symptoms: a potential early indicator for technology assessment? (2004) (13)
- Use of a Blood-patch Technique to Reduce Rectal Dose during Cesium-131 Prostate Brachytherapy (2008) (13)
- Bicalutamide alone prior to brachytherapy achieves cytoreduction that is similar to luteinizing hormone-releasing hormone analogues with less patient-reported morbidity. (2008) (13)
- RADIATION-ASSOCIATED MORBIDITY IN PATIENTS UNDERGOING SMALL-FIELD EXTERNAL BEAM IRRADIATION FOR PROSTATE CANCER (1999) (13)
- Stereotactic Body Radiation Therapy for Intermediate-risk Organ-confined Prostate Cancer: Interim Toxicity and Quality of Life Outcomes From a Multi-institutional Study (2012) (12)
- Radiation treatment of prostate bone metastases and the biological considerations. (1992) (12)
- Improved dosimetry in prostate brachytherapy using high resolution contrast enhanced magnetic resonance imaging: a feasibility study (2014) (11)
- Multinational Prospective Study of Patient-Reported Outcomes After Prostate Radiation Therapy: Detailed Assessment of Rectal Bleeding. (2016) (11)
- Accuracy of endorectal magnetic resonance/transrectal ultrasound fusion for detection of prostate cancer during brachytherapy. (2013) (10)
- Phase III study of ibuprofen versus placebo for radiation-induced genitourinary side effects. (2002) (9)
- MRI-ultrasound image fusion for 125I prostate implant treatment planning (1998) (8)
- Stereotactic Radiotherapy for Organ-confined Prostate Cancer: Early Toxicity and Quality of Life Outcomes from a Multi-institutional Trial (2010) (7)
- Fractionated Radiosurgery for Pancreas Cancer (2007) (7)
- Patient-Reported Quality of Life Outcomes in Intermediate-Risk Prostate Cancer Patients Treated With Stereotactic Body Radiation Therapy (2013) (7)
- Is there any benefit from hypofractionation in external-beam irradiation for prostate cancer? (2014) (7)
- Neoadjuvant Doxil Chemotherapy Prior to Androgen Ablation Plus Radiotherapy for High-Risk Localized Prostate Cancer: Feasibility and Toxicity (2003) (6)
- Stereotactic Body Radiation Therapy for Intermediate-Risk Prostate Cancer: Five-Year Outcomes From a Multi-institutional Study (2015) (6)
- Long-term efficacy of stereotactic body radiotherapy for localized prostate cancer: A multi-institutional pooled analysis. (2013) (6)
- Successful Patient Acceptance of Randomization Within the Pace Study (Prostate Advances in Comparative Evidence) (2013) (6)
- Medical oncology consultation and minimization of overtreatment in men with low-risk prostate cancer. (2014) (6)
- Long-term outcomes of stereotactic body radiotherapy for low- and intermediate-risk prostate adenocarcinoma: A multi-institutional consortium study. (2018) (6)
- Biochemical outcome following external beam radiation therapy with or without androgen suppression therapy for patients with clinically localized prostate cancer (2000) (5)
- 5-year outcomes after stereotactic ablative body radiotherapy for primary renal cell carcinoma: an individual patient data meta-analysis from IROCK (the International Radiosurgery Consortium of the Kidney). (2022) (5)
- 630: Initial Clinical Experience with Radiosurgical Ablation of Primary Renal Tumors Using Cyberknifetm : A Pilot Study (2007) (4)
- Radiotherapy for Incidental Adenocarcinoma of the Prostate (1991) (4)
- External beam radiotherapy for incidental adenocarcinoma of the prostate discovered at transurethral resection. (1992) (4)
- Individual Patient Data Meta-analysis of SBRT Kidney: A Report From the International Radiosurgery Oncology Consortium for Kidney (IROCK) (2017) (4)
- 19 Stereotactic Body Radiotherapy for Large Primary Large Renal Cell Carcinoma: A Report from the International Radiosurgery Oncology Consortium for Kidney (IROCK) (2019) (4)
- Phase II study of Enzalutamide with radiation therapy for intermediate risk prostate cancer: A phase 2 study. (2021) (4)
- 25 The impact of CT-simulation on the planning of tangential fields for left breast treatment (1999) (4)
- Hyperthermia Combined With Radiation in Treatment of Locally Advanced Prostate Cancer: Long-term Results of DFCI 94-153 (2007) (3)
- Long-Term Outcomes of Stereotactic Body Radiation Therapy for Low and Intermediate-Risk Prostate Adenocarcinoma: A Multi-Institutional Consortium Study (2018) (3)
- Minimizing rectal and urinary complications in prostate brachytherapy. (2000) (3)
- The Detection of Implanted Radioactive Seeds On Ultrasound Images Using Convolution Neural Networks (2018) (2)
- Response of blood flow to hyperthermia in human prostate tumors: Opportunities for enhanced radiation effect and drug delivery. (2014) (2)
- Patient Reported Outcomes in NRG Oncology/RTOG 0938, a Randomized Phase II Study Evaluating 2 Ultrahypofractionated Regimens (UHR) for Prostate Cancer (CaP) (2020) (2)
- Patient reported outcomes in NRG Oncology/RTOG 0938, evaluating two ultrahypofractionated regimens (UHR) for prostate cancer (CaP). (2016) (2)
- The role of PC-SPES, selenium, and vitamin E in prostate cancer. (2002) (2)
- Development of a pancreatic cancer prediction model using a multinational medical records database. (2021) (2)
- Stereotactic radiotherapy as a treatment option for renal tumours in the solitary kidney: a multicenter analysis from the International Radiosurgery Oncology Consortium for Kidney (IROCK). (2019) (2)
- Quality of Life Outcomes for Low- and Intermediate-Risk Prostate Cancer Patients Treated With 5-Fraction Stereotactic Body Radiation Therapy (2015) (1)
- SABR Produces Systemic Adaptive Immune Responses in Castration-Sensitive Oligometastatic Prostate Cancer Patients (2018) (1)
- Hyperthermia Combined with Radiation in Treatment of Locally Advanced Prostate Cancer Is Associated with a Favorable Toxicity Profile (2005) (1)
- External Validation of Early Quality of Life (QOL) Declines Correlated with Late QOL after Intensity Modulated, Low Dose Rate Brachytherapy, or Stereotactic Radiation for Prostate Cancer within a Prospective Trial (2020) (1)
- Stereotactic Body Radiotherapy for Large Primary Renal Cell Carcinoma: A Report from the International Radiosurgery Oncology Consortium for Kidney (IROCK) (2019) (1)
- Select transition zone prostate cancers may be radiocurable despite markedly elevated prostate-specific antigen levels. (1996) (1)
- Developing and validating a pancreatic cancer risk model for the general population using multi-institutional electronic health records from a federated network (2023) (1)
- Sterotactic body radiosurgery for primary small renal tumors: A retrospective analysis. (2014) (1)
- A Critical Examination of the Results from the Harvard-MIT NCT Program Phase I Clinical Trial of Neutron Capture Therapy for Intracranial Disease (2004) (1)
- Prostate-specific Antigen (PSA) Kinetics of the Early Response to CyberKnife Robotic Fractionated Radiosurgery of the Prostate: Correlated Regression Analysis of Combined Data from Three Institutions (2008) (1)
- Accuracy of Post-brachytherapy Dosimetric Data Derived from Computed Tomography (CT) versus Prostate Magnetic Resonance Imaging (MRI) (2013) (1)
- Predicting erectile function following external beam radiation therapy or brachytherapy for prostate cancer using EPIC-CP. (2018) (1)
- 637P Biochemical response (PSA0) and testosterone (T) recovery in Metacure, a multi-arm multi-modality (MM) therapy (tx) for very high risk localized (HRL) and low volume metastatic (LVM) prostatic adenocarcinoma (2021) (1)
- Impact of Rectal Bleeding on Quality of Life Measures After Prostate Radiation Therapy: Comparison of the EPIC-26 and EPIC-CP Instruments (2015) (1)
- Multidisciplinary care and management of very low-risk prostate cancer. (2013) (1)
- Development and validation of a pancreatic cancer prediction model from electronic health records using machine learning. (2020) (1)
- 1002 Equivalent 5 year bNED in select prostate cancer patients managed with surgery or radiation therapy despit exclusion of the seminal vesicles from the clinical target volume (1997) (1)
- 2204: Early Complications Following Contemporary Brachytherapy for Prostate Cancer in a Multi-Institutional Study at High Volume Health Centers in the US (2006) (1)
- 1772: Prostate Size, Obesity, and Neoadjuvant Hormone Therapy affect Hrqol in a Prospective, Multi-Center Study of Prostatectomy, External Radiotherapy, or Brachytherapy for Prostate Cancer (2007) (1)
- Real-time dosimetry in the operating room for 125I implants for prostate cancer (1998) (1)
- 2024 ROBOTIC RADIOSURGERY FOR ORGAN-CONFINED PROSTATE CANCER: EARLY TOXICITY OUTCOMES FROM A MULTI-INSTITUTIONAL TRIAL (2010) (1)
- Using patient-reported outcomes for technology assessment (TA) and quality improvement (QI) in prostate cancer brachytherapy (2007) (1)
- Melanoma Brain Metastases Treated With Brain-directed Radiation Followed by Ipilimumab (2012) (1)
- Intra-rectal application of amifostine for prevention of late radiation rectal injury: preliminary results of a phase i dose escalation study (2001) (1)
- Stereotactic Body Radiotherapy for Renal Cancer (2015) (0)
- Bicalutamide monotherapy achieves comparable cytoreduction prior to interstitial brachytherapy and represents an effective, less expensive, less morbid alternative to luteinizing hormone-releasing hormone analogues (2004) (0)
- PREDICTING URINARY FUNCTION AFTER PROSTATE CANCER TREATMENT: A MULTIVARIABLE NOMOGRAM FROM THE PROSTQA CONSORTIUM (2009) (0)
- Five-year patient reported outcomes in NRG Oncology RTOG 0938, evaluating two ultrahypofractionated regimens for prostate cancer. (2022) (0)
- Prostate brachytherapy technique and long-term urinary incontinence: 5-year outcomes of a prospective comparative cohort study. (2014) (0)
- OC-0509 10-year outcome of ultrahypofractionated stereotactic RT from two multicenter prostate cancer trials (2021) (0)
- Physician Bias, Referral to a Medical Oncologist, and Active Surveillance in Low-risk Prostate Cancer (2012) (0)
- The "bottom line"--response to Dr. Hanks. (1992) (0)
- Multidisciplinary care and pursuit of active surveillance in low-risk prostate cancer. (2012) (0)
- Improving the survivorship care plan process across an academic and community cancer center. (2019) (0)
- Long-Term Outcomes from a Multi-Center Trial of Stereotactic Body Radiotherapy for Low- and Intermediate-Risk Prostate Cancer (2019) (0)
- Enzalutamide Monotherapy with EBRT for Intermediate Risk Prostate Cancer. A Phase 2 Study (2019) (0)
- Response to Dr. Lee (1994) (0)
- Time C ourse a nd P redictors o f S ymptoms A fter P rimary Prostate C ancer T herapy (2008) (0)
- Does prostate brachytherapy that avoids the central zone prevent long-term urinary incontinence? Five-year results of a multi-institutional comparative cohort study. (2011) (0)
- 1605: Prostate Cancer Physician Performance Measured by Patient-Reported Ratings of Practitioner Manner/Skill and by Treatment-Related Adverse Events (2006) (0)
- Focal Therapy for Prostate Cancer Using Radiation (2011) (0)
- A preloaded 22-gauge fine-needle system facilitating placement of a higher number of fiducials for image-guided radiation therapy compared with traditional backloaded 19-gauge approach. (2021) (0)
- Long-Term Outcomes of SABR to Primary Renal Cell Carcinoma: A Multicenter Analysis from IROCK (International Radiosurgery Oncology Consortium for Kidney) (2022) (0)
- Assessing Patient Perceptions of Goals of Treatment After Consent for Palliative Radiation Therapy (2016) (0)
- Response to Dr. Coleman's review: PSA kinetics, model building, and clinical practice (1994) (0)
- In Reply to Drs. Beaulieu and Verhagen (2008) (0)
- A Deep Learning Approach to Radioactive Seed Detection for Prostate Seed Implants (2019) (0)
- System and methods for overdose mitigation (2017) (0)
- Multi-institutional analysis of high-risk prostate cancer patients treated with stereotactic body radiotherapy. (2019) (0)
- RTOG/NRG 1115 Quality of Life of Phase III Dose Escalated Radiation Therapy (RT) and Standard Androgen Deprivation Therapy (ADT) with GnRH Agonist vs. Dose Escalated RT and ADT with GnRH Agonist and Orteronel (TAK-700) for Men with High-Risk Prostate (2022) (0)
- Using patient-reported outcomes to assess prostate brachytherapy technique (2005) (0)
- Development and Experience with Cancer Risk Prediction Models Using Federated Databases and Electronic Health Records (2022) (0)
- Evaluation of a prostate brachytherapy technique designed to reduce short- and long-term urinary dysfunction: 5-year results of a multi-institutional comparative cohort study. (2011) (0)
- Multi-institutional Prospective Evaluation of Bowel Quality of Life after Prostate External Beam Radiation Therapy Identifies Patient and Treatment Factors Associated with Patient Reported Outcomes (2011) (0)
- Transrectal ultrasound prostate hyperthermia is associated with minimal toxicity when administered with radiation in treatment of locally advanced prostate cancer (2000) (0)
- Predictive Factors for Urinary Toxicity from a Multi-Center Trial of Stereotactic Body Radiation Therapy for Prostate Cancer (2018) (0)
- Renal SABR in Patients with a Solitary Kidney: An Individual-Patient Pooled Analysis from the International Radiosurgery Oncology Consortium for Kidney (IROCK) (2018) (0)
- 694 ALLEVIATION VERSUS INDUCTION OF URINARY OBSTRUCTION OR INCONTINENCE BY PROSTATE CANCER TREATMENT THE PIVOTAL ROLE OF PRETREATMENT URINARY SYMPTOMS (2012) (0)
- Automatic detection of linear artifacts in medical images. (2004) (0)
- Stereotactic body radiotherapy boost toxicity for high and intermediate-risk prostate cancer: Report of a multi-institutional study. (2020) (0)
- Impact of Body Deformation in Radiosurgery Using Respiratory Tracking (2007) (0)
- Early Quality of Life (QOL) Declines Correlate With Later QOL After Intensity Modulated Radiation Therapy, Low-Dose-Rate Brachytherapy, or Stereotactic Radiation for Prostate Cancer (2014) (0)
- Pretreatment N omogram f or P rostate-Specifi c A ntigen Recurrence A fter R adical P rostatectomy o r E xternal-Beam Radiation T herapy f or C linically L ocalized P rostate C ancer (1999) (0)
- PD63-05 EMULATING A CLINICAL TRIAL OF RADICAL PROSTATECTOMY VERSUS EXTERNAL BEAM RADIATION THERAPY FOR HIGH-GRADE, CLINICALLY LOCALIZED PROSTATE CANCER (2020) (0)
- A critical examination of the results from the phase I clinical trial of cranial neutron capture therapy at Harvard-MIT: normal tissue reaction and initial tumor response (2002) (0)
- Survivorship care plans: Implementation in an academic medical center. (2018) (0)
- Predicting return of erectile function following external beam radiotherapy or brachytherapy for prostate cancer using EPIC-CP. (2016) (0)
- The effect of prostate brachytherapy technique on quality of life outcomes: 5-year outcomes of a prospective cohort study. (2014) (0)
- The International Radiosurgery Oncology Consortium for Kidney (IROCK) multicentre analysis of SABR for primary RCC in patients with or without prior nephrectomy (2018) (0)
- Referral to a Multidisciplinary Genitourinary Oncology Clinic Increases Rates of Active Surveillance in Low-risk Prostate Cancer (2011) (0)
- Radiation Oncology Scientific Exhibits (2018) (0)
- MP14-17 PREDICTING ERECTILE FUNCTION FOLLOWING RADIATION THERAPY FOR PROSTATE CANCER AT THE POINT OF CARE (2016) (0)
- UTILIZATION OF MEDICATIONS AND DEVICES FOR ERECTILE DYSFUNCTION AFTER PROSTATE CANCER TREATMENT: RESULTS FROM THE MULTICENTER PROSTQA CONSORTIUM (2009) (0)
- Toxicity After Stereotactic Body Radiation Therapy for Prostate Cancer in Patients With Inflammatory Bowel Disease: A Multi-institutional Matched Case-Control Series (2021) (0)
- MP51-10 PREDICTORS OF FAVORABLE URINARY OUTCOMES AFTER PROSTATE CANCER TREATMENT (2014) (0)
- Grading our quality: An academic and community cancer center dashboard. (2022) (0)
- Prostate Cancer Screening and Surveillance—Reply (2009) (0)
- 10 Year Prostate Stereotactic Body Radiotherapy Outcomes: Relapse-free Survival, PSA Kinetics And Toxicity From A Pooled Analysis Of Two Multi-Institutional Trials (2020) (0)
- A secondary analysis of PSA response in NRG Oncology/RTOG 9902: A phase III trial of adjuvant chemotherapy with androgen suppression and radiation for high-risk prostate cancer (CaP). (2017) (0)
- Survivorship Care Plans: Reaching a Benchmark and Striving to Achieve Intent. (2020) (0)
- Assessment of freedom from biochemical failure for low risk clinically localized prostate cancer patients supports use of conventional dose radiation in this patient population (2001) (0)
- Comparative Effectiveness Analysis of Patient-Reported Quality of Life (QOL) After Stereotactic Body Radiation Therapy as Compared to Intensity Modulated Radiation Therapy or Low-Dose-Rate Brachytherapy up to 2 Years After Treatment (2014) (0)
- Investigation Into the Feasibility of Having Uniform Compliance Dosimetric Criteria Across Radiation Therapy Treatment Modalities for NRG Oncology/RTOG 0938 by Using Machine Learning (2016) (0)
- Phase II study of enzalutamide monotherapy with radiation therapy for intermediate risk prostate cancer. (2018) (0)
- Su1381 EUS-GUIDED FIDUCIAL PLACEMENT FOR IMAGE-GUIDED RADIATION THERAPY IN PANCREATICOBILIARY MALIGNANCY USING A NOVEL PRELOADED 22-GAUGE NEEDLE (2018) (0)
- Response of Extracranial Lesions After Treatment of Metastatic Melanoma With Cranial Radiation and Ipilimumab (2014) (0)
- Postprostatectomy External Beam Irradiation (1999) (0)
This paper list is powered by the following services:
Other Resources About Irving D. Kaplan
What Schools Are Affiliated With Irving D. Kaplan?
Irving D. Kaplan is affiliated with the following schools:
